Zohar Zisapel - Amdocs Independent Director

DOX
 Stock
  

USD 84.45  1.14  1.37%   

  Director
Mr. Zohar Zisapel serves as Independent Director of Amdocs Limited. He was a director of Amdocs since 2008 and is the Chairman of the Technology and Innovation Committee. Mr. Zisapel cofounded RAD Data Communications Ltd., a privatelyheld voice and data communications company and part of the RAD Group, a family of independent networking and telecommunications companies, and was its CEO from 1982 until 1998 and Chairman from 1998 until 2012. Mr. Zisapel also serves as chairman of Ceragon Networks Ltd. and as a director of Radcom Ltd., both public companies traded on Nasdaq, and on the boards of directors of several privatelyheld companies. Mr. Zisapel served as chairman of the Israel Association of Electronic Industries from 1998 until 2001
Age: 68  Director Since 2008  Ph.D    
(44) 1481 728444  www.amdocs.com
Zisapel received an Honorary Doctorate from the Technion — Israel Institute of Technology, and he is teaching Entrepreneurship at the Tel Aviv University.

Amdocs Management Efficiency

Amdocs Limited has Return on Asset of 5.76 % which means that on every $100 spent on asset, it made $5.76 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 14.03 %, implying that it generated $14.03 on every 100 dollars invested. Amdocs management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Return on Invested Capital is likely to rise to 0.44 in 2022, whereas Return on Investment is likely to drop 12.42 in 2022. Amdocs Tax Assets are fairly stable at the moment as compared to the past year. Amdocs reported Tax Assets of 135.66 Million in 2021. Revenue to Assets is likely to rise to 0.60 in 2022, whereas Total Assets are likely to drop slightly above 7 B in 2022.
The company has 879.12 M in debt with debt to equity (D/E) ratio of 0.25, which may show that the company is not taking advantage of profits from borrowing. Amdocs Limited has a current ratio of 1.47, which is typical for the industry and considered as normal. Debt can assist Amdocs until it has trouble settling it off, either with new capital or with free cash flow. So, Amdocs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amdocs Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amdocs to invest in growth at high rates of return. When we think about Amdocs' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

DIRECTOR Since

Thomas CechMerck Company
2009
Laurie ThomsenThe Travelers Companies
2004
Leslie BrunMerck Company
2016
Kristina JohnsonCisco Systems
2012
Thomas HodgsonThe Travelers Companies
1997
Carl BassHp Inc
2015
Caroline TsayCoca-Cola
2018
Prem WatsaBlackberry
2013
Thomas HortonWalmart
2014
Richard DaleyCoca-Cola
2011
David WeinbergCoca-Cola
2015
Brian HallaCisco Systems
2007
Carlos RepresasMerck Company
2009
Inge ThulinMerck Company
2018
Ganesh RaoBlack Knight
2014
Joseph EchevarriaPfizer Inc
2015
Roderick McGearyCisco Systems
2003
Barbara StymiestBlackberry
2013
Marissa MayerWalmart
2012
James SmithPfizer Inc
2014
Plengsak PrakatphesatBlack Knight
2005
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 29000 people. Amdocs Limited (DOX) is traded on NASDAQ Exchange in USA. It is located in Hirzel House, Smith Street, St. Peter Port, Island of Guernsey GY1 2NG, United Kingdom and employs 29,000 people. Amdocs is listed under Business Services category by Fama And French industry classification.

Amdocs Limited Leadership Team

Elected by the shareholders, the Amdocs' board of directors comprises two types of representatives: Amdocs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amdocs. The board's role is to monitor Amdocs' management team and ensure that shareholders' interests are well served. Amdocs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amdocs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Richard LeFave, Independent Director
Matthew Smith, Corporate Secretary
John MacDonald, Director
Adrian Gardner, Independent Director
Tamar RapaportDagim, Senior Vice President and CFO of Amdocs Management Limited
Zohar Zisapel, Independent Director
Simon Olswang, Independent Director
Anshoo Gaur, Division President of Amdocs Devel. Center India Pvt Ltd
Elizabeth McDermon, Secretary and VP of Corporate Strategy of Amdocs Inc.
Giora Yaron, Director
Shuky Sheffer, Senior Vice President and President of Customer Business Group, Amdocs Management Limited
John McLennan, Independent Director
Robert Minicucci, Independent Chairman of the Board
Matt Smith, IR Contact Officer
Clayton Christensen, Director
Julian Brodsky, Independent Director
James Kahan, Independent Director
Eli Gelman, Director, Member of Technology and Innovation Committee, CEO of Amdocs Management Limited and President of Amdocs Management Limited
Rajat Raheja, Division President Amdocs Development Center India Pvt. Ltd

Amdocs Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amdocs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Amdocs Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs Limited to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.